Clinical research study for advanced or metastatic non-small cell lung cancer (NSCLC)

See if you may be eligible for the CONEXIO-LC1 study.

This clinical research study aims to find out if an investigational treatment(s) may be well-tolerated and effective for adults with advanced or metastatic NSCLC.

This website provides information about a clinical study, CONEXIO-LC1, for adults with advanced or metastatic NSCLC whose cancer has come back or kept growing after other treatments. This study is also looking at how safe these treatments are and how well they are tolerated.

This clinical trial will use an investigational treatment(s), the safety and efficacy of which has not been fully evaluated by Regulatory Authorities.

Clinical studies are essential to investigating potential treatments and are not possible without the people who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of advanced or metastatic NSCLC, which may help others in the future with this condition.

Living with advanced or metastatic NSCLC may feel overwhelming, and you may feel that you have enough to do without committing to a clinical study. However, you may play a key role in helping to develop therapies that are being studied to help advance our medical knowledge of advanced or metastatic NSCLC. Every treatment that exists today is available because of study participants who actively took part in research.

Learn more about CONEXIO-LC1 and see if it may an option for you.

Testimonials

“The biggest advantage of taking part in a clinical trial is that you’re shaping the future of cancer care. All drugs have to go through this process, so it’s like you’re shaping the future of medication for your family, for your community, for the world.”

Cara

“I think clinical trials are important for the person going through them if there is a potential benefit, but also for anybody else who is going to be fighting cancer… Anything that can help the future of fighting cancer… that we can be a part of, we’d happily do that.”

Jeremy

Disclaimer: Cara and Jeremy have not participated in any Regeneron clinical trials.